Go To Offers
Marketplace Regolith
Your investment opportunities
Verve Therapeutics
🏁 Closed
Gene editing for cardiovascular diseases
Updated on 12 Feb 2026
$0
Price
$0
Min. investment
🏁 Closed
IPO
Profit
+203.95%
Updated on 12 Feb 2026
Verve Therapeutics
🏁 Closed
Gene editing for cardiovascular diseases
Updated on 12 Feb 2026
$0
Price
$0
Min. investment